IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
Loading...

APC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_APC_122007
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
  • BM8_APC_122007
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
123115 25 µg 40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123116 100 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The F4/80 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  2. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  3. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  4. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  5. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  6. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  7. Chen J, et al. 2022. Adv Sci (Weinh). 9:e2200668. PubMed
  8. Sipilä K, et al. 2022. Dev Cell. 57:1453. PubMed
  9. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  10. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  11. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  12. Schaue D, et al. 2022. Antioxidants (Basel). 11: . PubMed
  13. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  14. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  15. Yoo HJ, et al. 2022. Cell Rep. 41:111598. PubMed
  16. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  17. Miao Y, et al. 2022. Front Pharmacol. 13:1032741. PubMed
  18. Kuo CS, et al. 2022. Elife. 11: . PubMed
  19. Lee DE, et al. 2022. Nat Commun. 13:7613. PubMed
  20. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  21. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  22. Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed
  23. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  24. Fontana MF, et al. 2023. Elife. 12: . PubMed
  25. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  26. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  27. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  28. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  29. Li S, et al. 2023. Exp Mol Med. 55:457. PubMed
  30. Li FJ, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L593. PubMed
  31. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  32. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  33. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  34. Quattrocelli M, et al. 2022. J Exp Med. 219:. PubMed
  35. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  36. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  37. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  38. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Czimmerer Z, et al. 2022. Immunity. 55:2006. PubMed
  40. Amodio V, et al. 2023. Cancer Cell. 41:196. PubMed
  41. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  42. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  43. Liu PS, et al. 2023. Nat Immunol. 24:452. PubMed
  44. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  45. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  46. Spitzer D, et al. 2023. Nat Protoc. 18:1510. PubMed
  47. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  48. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  49. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  50. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  51. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  52. He XY, et al. 2023. Nat Commun. 14:2253. PubMed
  53. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  54. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  55. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  56. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  57. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  58. He Y, et al. 2023. Biomolecules. 13:. PubMed
  59. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  60. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  61. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  62. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  63. Yang D, et al. 2022. Cell. 185:1905. PubMed
  64. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  65. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  66. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  67. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  68. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  69. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  70. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  71. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  72. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  73. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  74. Nguyen T, et al. 2021. STAR Protoc. 2:101004. PubMed
  75. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  76. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  77. Yan X, et al. 2022. Commun Biol. 5:320. PubMed
  78. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  79. He R, et al. 2021. J Immunol. 206:2353. PubMed
  80. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  81. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  82. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  83. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  84. He F, et al. 2021. J Exp Med. 218:. PubMed
  85. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
  86. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  87. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  88. Bousset L, et al. 2020. PLoS Biol. 18:e3000948. PubMed
  89. Yu J, et al. 2020. Sci Rep. 10:21360. PubMed
  90. Sharma-Chawla N, et al. 2016. Infect Immun . . PubMed
  91. Emal D, et al. 2016. J Am Soc Nephrol. 10.1681/ASN.2016030255. PubMed
  92. Dale M, et al. 2016. J Immunol. 196: 4536 - 4543. PubMed
  93. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  94. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  95. Bieren J, et al. 2015. J Immunol. 194:1154. PubMed
  96. Prantner D, et al. 2009. Infect Immun. 77:5334. PubMed
  97. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  98. Kim SE, et al. 2019. Nutrients. 11. PubMed
  99. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  100. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  101. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  102. Yates C, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0644-9. PubMed
  103. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  104. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  105. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  106. Stubelius A, et al. 2012. Immunobiology. 217:751. PubMed
  107. Sjöstrand M, et al. 2013. J Immunol. 191:3753. PubMed
  108. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  109. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  110. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  111. Dong L, et al. 2021. Cancer Cell. . PubMed
  112. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  113. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  114. Han J, et al. 2022. FEBS J. 289:417. PubMed
  115. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  116. Liang F, et al. 2021. Front Immunol. 12:658715. PubMed
  117. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  118. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  119. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  120. Xu Y, et al. 2020. Mol Ther. 28:202. PubMed
  121. Mia MM, et al. 2020. PLoS Biol. 18:e3000941. PubMed
  122. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  123. Zhu J, et al. 2016. Sci Rep. 6:27136. PubMed
  124. Sun P, et al. 2015. J Hepatol. . PubMed
  125. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  126. Gritsina G, et al. 2015. Mol Cancer Ther. 14:1035. PubMed
  127. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  128. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  129. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  130. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  131. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  132. Qi F, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.05.008. PubMed
  133. Stefan K, et al. 2017. PLoS One. . 10.1371/journal.pone.0188600. PubMed
  134. Sinha M, et al. 2018. Nat Commun. 9:936. PubMed
  135. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  136. Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
  137. Christopher S Garris et al. 2018. Immunity. 49(6):1148-1161 . PubMed
  138. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  139. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  140. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  141. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  142. Tajfirouz D, et al. 2017. Virology. 10.1016/j.virol.2017.02.022. PubMed
  143. Krivanek J, et al. 2020. Nat Commun. 3.802777778. PubMed
  144. Brestoff JR, et al. 2021. Cell Metab. 33:270. PubMed
  145. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  146. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  147. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  148. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  149. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  150. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  151. Kosaric N, et al. 2020. Mol Ther. 28:2007. PubMed
  152. Ling X, et al. 2021. ACS Nano. 15:765. PubMed
  153. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  154. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  155. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  156. Shang Y, et al. 2016. Nat Immunol. 10.1038/ni.3486. PubMed
  157. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  158. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  159. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  160. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  161. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  162. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  163. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  164. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  165. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  166. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  167. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  168. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  169. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  170. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  171. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  172. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  173. Prantner D, et al. 2011. Infect Immun. 79:3922. PubMed
  174. Helmi N, et al. 2015. J Infect Dis. 211:1677. PubMed
  175. Tsoyi K, et al. 2015. J Leukoc Biol. 97:171. PubMed
  176. Ma Y, et al. 2015. Cardiovasc Res. 106:421. PubMed
  177. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  178. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  179. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  180. Sun L, et al. 2020. J Immunol. 2177:204. PubMed
  181. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  182. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  183. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  184. Lv F, et al. 2022. iScience. 25:103639. PubMed
  185. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  186. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  187. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  188. Gao H, et al. 2021. Cells. 10:. PubMed
  189. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  190. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  191. Amash A, et al. 2016. J Immunol. 196: 3331-3340. PubMed
  192. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  193. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  194. Oatley J, et al. 2009. Development. 136:1191. PubMed
  195. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  196. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  197. Yu Y, et al. 2019. J Clin Invest. 129:546. PubMed
  198. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  199. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  200. Chen F et al. 2018. Cell reports. 25(10):2775-2783 . PubMed
  201. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  202. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  203. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  204. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  205. Hara-Chikuma H 2016. Mol Cell Biol. 36: 1206-1218. PubMed
  206. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  207. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  208. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  209. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  210. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  211. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  212. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  213. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  214. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  215. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  216. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  217. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  218. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  219. Wang W, et al. 2018. Oncogenesis. 7:97. PubMed
  220. Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
  221. Wang T, et al. 2018. Front Physiol. 9:209. PubMed
  222. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  223. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  224. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  225. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  226. Matundan H, et al. 2019. J Virol. 93. PubMed
  227. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  228. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  229. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  230. Fairfax K, et al. 2013. J Immunol. 191:4202. PubMed
  231. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  232. Toda G, et al. 2021. STAR Protoc. 2:100246. PubMed
  233. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  234. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  235. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  236. Pfefferlé M, et al. 2021. Front Immunol. 12:680855. PubMed
  237. Wara AK, et al. 2020. Cell Rep. 33:108550. PubMed
  238. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  239. Yang Y, et al. 2022. Elife. 11:. PubMed
  240. Chung EJ, et al. 2022. Aging (Albany NY). 14:7692. PubMed
  241. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  242. Lang V, et al. 2021. Elife. 10:. PubMed
  243. Jaggi U, et al. 2021. PLoS Pathog. 17:e1009999. PubMed
  244. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  245. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  246. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  247. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  248. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  249. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  250. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  251. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  252. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  253. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  254. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  255. Kuwahara G, et al. 2014. PLoS One. 9:106987. PubMed
  256. Patankar Y, et al. 2013. Infect Immun . 81:2043. PubMed
  257. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  258. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  259. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  260. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  261. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  262. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  263. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  264. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  265. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  266. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  267. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  268. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  269. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  270. Cao Q, et al. 2019. Theranostics. 5.576388889. PubMed
  271. Kim K, et al. 2014. Proc Natl Acad Sci U S A. 111:11774. PubMed
  272. Hu J, et al. 2015. J Hepatol. Available online 31 August 2015. PubMed
  273. Terrazas M 2014. Int J Parasit. 44 613 . PubMed
  274. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  275. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  276. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  277. Ye ZH, et al. 2021. Transl Oncol. 14:101162. PubMed
  278. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  279. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  280. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  281. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  282. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  283. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  284. Chen F, et al. 2022. Cell Rep. 38:110215. PubMed
  285. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  286. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  287. Calle P, et al. 2021. Cells. 10:. PubMed
  288. Ishikura S, et al. 2021. J Cell Biochem. . PubMed
  289. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  290. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  291. Chen Z, et al. 2016. Nat Commun. 7:11596. PubMed
  292. Deng W, et al. 2015. Clin Immunol. . PubMed
  293. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  294. Shaw O, et al. 2014. Rheumatology. 53:1901. PubMed
  295. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  296. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  297. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  298. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  299. Engblom C, et al. 2017. Science. 358:6367. PubMed
  300. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  301. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  302. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  303. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  304. Horsle B 2013. Development. 140:1517. PubMed
  305. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  306. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  307. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  308. Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
  309. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  310. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  311. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
  312. Toda G, et al. 2020. Molecular Cell. 79(1):43-53.e4. PubMed
  313. Karki R, et al. 2020. bioRxiv. . PubMed
  314. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  315. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  316. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  317. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  318. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  319. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  320. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  321. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  322. Panagi M, et al. 2020. Theranostics. 10:1910. PubMed
  323. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  324. Gu H, et al. 2021. Elife. 10:. PubMed
  325. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  326. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  327. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  328. Karki R, et al. 2021. Cell. 184:149. PubMed
  329. Caoa X, et al. 2017. Neurosci Lett. 10.1016/j.neulet.2017.02.045. PubMed
  330. Jeurissen M, et al. 2016. PLoS One. 11:e0167199. PubMed
  331. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  332. Neimert-Andersson T, et al. 2011. Vaccine. 29:8965. PubMed
  333. Sun L, et al. 2009. FASEB J. 3.602777778. PubMed
  334. Esposito E, et al. 2019. Nat Commun. 4.101388889. PubMed
  335. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  336. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  337. Nishino T, et al. 2018. Arterioscler Thromb Vasc Biol. 38:2460. PubMed
  338. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  339. Singh KS, et al. 2020. Nat Commun. 0.786805556. PubMed
  340. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  341. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  342. Mirsoian A, et al. 2014. J Exp Med. 211:2373. PubMed
  343. Yin X, et al. 2015. J Immunol. 194:4029. PubMed
  344. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  345. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  346. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  347. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  348. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  349. Ling X, et al. 2021. Biomaterials. 270:120690. PubMed
  350. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  351. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  352. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  353. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  354. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  355. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  356. Liu SS, et al. 2021. Immunity. :. PubMed
  357. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  358. Cao H, et al. 2020. Front Pharmacol. 11:578943. PubMed
  359. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  360. Sockolosky J, et al. 2016. Proc Natl Acad Sci U S A. 113: 2646 - 2654. PubMed
  361. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  362. Ishizuka M, et al. 2015. PLoS One. 10: 0137978. PubMed
  363. Pechous R, et al. 2015. MBio. 6:2302. PubMed
  364. Yin T, et al. 2015. J Immunol. 194:429. PubMed
  365. Klezovich-Bénard M, et al. 2012. PLoS One. 8:e1002481. PubMed
  366. Karpurapu M, et al. 2011. Blood. 118:5255. PubMed
  367. Yan K, et al. 2020. Cell Death Dis. 1.013888889. PubMed
  368. Eghbalzadeh K, et al. 2019. Front Immunol. 2.022916667. PubMed
  369. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  370. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  371. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  372. Koupenova M, et al. 2019. iScience. 19:916. PubMed
  373. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  374. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  375. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  376. Kim M, et al. 2012. J Immunol. 188:4158. PubMed
  377. Collins C, et al. 2014. Proc Natl Acad Sci U S A. 111:9899. PubMed
  378. Bramwell K, et al. 2015. J Immunol. 195: 1647 - 1656. PubMed
  379. Legrain S, et al. 2015. J Immunol. 195: 4171 - 4175. PubMed
  380. Schuijs M, et al. 2016. PLoS One. 11: 016188. PubMed
  381. Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed
  382. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  383. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  384. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  385. Gardner A, et al. 2022. J Immunother Cancer. 10:. PubMed
  386. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  387. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  388. Chung EJ, et al. 2021. Int J Radiat Oncol Biol Phys. 110:526. PubMed
  389. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  390. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  391. Liu ZZ, et al. 2021. Front Immunol. 12:636861. PubMed
  392. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  393. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  394. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  395. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  396. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  397. Malik M, et al. 2012. Proc Natl Acad Sci U S A. 109:6130. PubMed
  398. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  399. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  400. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  401. Sparber F et al. 2019. British journal of pharmacology. 176(11):1728-1744 . PubMed
  402. Lalor R, et al. 2019. Nutrients. 11. PubMed
RRID
AB_893481 (BioLegend Cat. No. 123115)
AB_893481 (BioLegend Cat. No. 123116)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
F4/80
Specificity Alt (DOES NOT SHOW ON TDS):
F4/80
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark Red™ 718 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Spark Blue™ 574 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Go To Top Version: 2    Revision Date: 10-25-2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account